This trial will test whether patients with a certain type of stroke do better with a medical procedure than with initial medical management.
3 Primary · 11 Secondary · Reporting Duration: 96 hours
Active Control
Experimental Treatment
200 Total Participants · 2 Treatment Groups
Primary Treatment: Immediate mechanical thrombectomy(iMT) using EmboTrap II Revascularization Device · No Placebo Group · Phase 2 & 3
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: